Cytosorbents (CTSO) Change in Intangibles (2010 - 2026)
Cytosorbents (CTSO) reported Change in Intangibles of $61000.0 for Q1 2026, up 35.56% on a YoY basis from $45000.0 in Q1 2025, and down 76.45% quarter-over-quarter from $259000.0 in Q4 2025.
Cytosorbents (CTSO) Change in Intangibles (2010 - 2026) Analysis & Trends
Cytosorbents has reported Change in Intangibles for 17 years, with the latest figure at $61000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Intangibles rose 35.56% year-over-year to $61000.0; the trailing twelve-month figure through Mar 2026 stood at $343000.0 (down 1.49% YoY), and the FY2025 full-year result was $327000.0, down 15.06% from the prior year.
- Change in Intangibles for Q1 2026 stood at $61000.0, down from $259000.0 in the prior quarter.
- The five-year high for Change in Intangibles was $259000.0 in Q4 2025, with the low at -$72000.0 in Q3 2025.
- Historically, Change in Intangibles has averaged $90548.9 across 5 years, with a median of $81827.0 in 2024.
- Annual changes were most pronounced in 2023 — Change in Intangibles jumped 649.48% — and 2025, when it plunged 148.98%.
- Cytosorbents' Change in Intangibles stood at -$7357.0 in 2022, then jumped by 649.48% to $40425.0 in 2023, then soared by 36.05% to $55000.0 in 2024, then surged by 370.91% to $259000.0 in 2025, then plunged by 76.45% to $61000.0 in 2026.
- The last three Change in Intangibles figures came in at $61000.0 (Q1 2026), $259000.0 (Q4 2025), and -$72000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -31.61 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Cytosorbents | 28.80 Mn | 24.00 Mn | 6.13 Mn | 61,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61,000.00 |
| Mar 31, 2026 | 61,000.00 |
| Dec 31, 2025 | 259,000.00 |
| Dec 31, 2025 | 259,000.00 |
| Sep 30, 2025 | -72,000.00 |
| Sep 30, 2025 | -72,000.00 |
| Jun 30, 2025 | 95,000.00 |
| Jun 30, 2025 | 95,000.00 |
| Mar 31, 2025 | 45,000.00 |
| Mar 31, 2025 | 45,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2024 | 147,000.00 |
| Sep 30, 2024 | 147,000.00 |
| Jun 30, 2024 | 101,173.00 |
| Jun 30, 2024 | 101,173.00 |
| Mar 31, 2024 | 81,827.00 |
| Mar 31, 2024 | 81,827.00 |
| Dec 31, 2023 | 40,425.00 |
| Dec 31, 2023 | 40,425.00 |